News | Ultrasound Imaging | June 12, 2019

Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership With EmCyte Corp.

Three-day workshop will enhance attendees’ knowledge of ultrasound-guided procedures and therapies for musculoskeletal specialties

Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership With EmCyte Corp.

June 12, 2019 — Konica Minolta Healthcare announced a new autologous biologics workshop in partnership with EmCyte Corp. The workshop is part of Konica Minolta Healthcare’s UGPro Solution, an initiative that provides complete solutions for ultrasound-guided procedures and therapies featuring the company’s Sonimage HS1 and Sonimage MX1 ultrasound systems, and including hands-on education and training.

The Autologous Biologics Training Series: Advanced Orthobiology and Sports Medicine for Upper & Lower Extremity Disorders, will be held at EmCyte Corp.’s not-for-profit regenerative medicine training and educational organization, Gulf Coast Biologics, in Fort Myers, Fla. The workshop takes place June 21-23 and is designated for a maximum 17.75 AMA PRA Category 1 Credits by Albert Einstein College of Medicine.

Autologous biologics, for use in regenerative medicine, is a growing field in musculoskeletal (MSK) specialty. Many states are now requiring certification for a clinician to perform ultrasound-guided diagnosis and therapy. This course will enhance the attendees’ knowledge of regenerative medicine with a review of the latest technology in advanced autologous biologics, evidence-based outcomes in biological cell therapeutics and treatment options with biological injections. In addition to learning the principles of MSK ultrasound, participants will also review state scanning protocols and appropriate transducer selection, presets and system optimization features. Hands-on learning using Konica Minolta Healthcare’s Sonimage HS1 and Sonimage MX1 ultrasound systems include diagnostic MSK ultrasound and image-guided intra-articular and intra-tendinous biologic injections on the upper and lower extremities of cadaver specimen.

The latest software release for the HS1 System was developed to enhance the user experience and raise the level of patient care during MSK scanning and interventions. Designed for ease of use and to improve workflow, the UltraAdjust image optimization feature allows imaging parameters to be changed by simply adjusting the depth. Hands-free operation during interventional procedures is enabled with an artificial intelligence (AI)-based voice recognition technology that controls system functions through simple voice commands. Panoramic imaging delivers both qualitative and quantitative information for the clinician by enabling the assessment of larger lesions, constructing a cross-section image of a structure and depicting the relationship of two structures in a single image.

For more information: www.konicaminolta.com/medicalusa

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Image by rawpixel from Pixabay

Image by rawpixel from Pixabay 

Feature | Radiology Business | July 18, 2019 | By Stefanie Manack and Judy Zakutny
Approximately 30 percent of a hospital or health system’s profit comes from imaging according, to...
Mirion Showcases Instadose2 Wireless Dual Detector Dosimeter at AAPM and AHRA
News | Radiation Dose Management | July 15, 2019
Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)]...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...